Senzime AB (publ) announced that it has secured a purchasing contract with the number one ranked children?s hospital system in the United States for its TetraGraph® quantitative neuromuscular monitoring system. The contract was awarded following a comprehensive competitive evaluation and once fully implemented, the TetraGraph system will be utilized in over 40 operating rooms, supporting more than 30,000 surgeries annually. Each year, approximately 100 million patients, including children, receive neuromuscular blocking drugs as part of anesthesia to facilitate endotracheal intubation and optimize surgical conditions.

These medications paralyze muscles required for breathing, making accurate monitoring during surgery essential for ensuring each patient receives the appropriate dose for a safe and timely recovery.